ST诺泰(688076.SH)通过药品cGMP现场检查

Core Viewpoint - ST诺泰 has received the CBPF-GMP certificate from Brazil's National Health Surveillance Agency (ANVISA), indicating compliance with international production quality standards for its active pharmaceutical ingredients, semaglutide and liraglutide [1] Group 1 - The inspection covered the company's cGMP system at its Lianyungang factory, which includes the production lines for semaglutide and liraglutide [1] - The company has now passed compliance checks from multiple international regulatory bodies, including the FDA and MFDS, enhancing its credibility in the global market [1] - This certification will facilitate the company's product sales and promotion in overseas markets, aligning with international regulatory standards [1]